Results 141 to 150 of about 986,956 (307)

ELISA Test Based on the Phenolic Glycolipid-I (PGL-I) of Mycobacterium leprae: A Reality of a Laboratory from a Non-Endemic Country. [PDF]

Pathogens, 2022
Longoni SS, Beltrame A, Prato M, Spencer JS, Bergamaschi N, Clapasson A, Parodi A, Piubelli C, Perandin F.   +8 more
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included.
Ellen Romich, Alexis Ogdie, Alisa Stephens Shields, Peter A. Merkel, Shervin Assassi, Elana J. Bernstein, Andreea Bujor, Flavia V. Castelino, Lorinda Chung, Luke B. Evnin, Tracy M. Frech, Jessica K. Gordon, Melissa Griffith, Faye N. Hant, Monica L. Harding, Laura K. Hummers, Dinesh Khanna, Kimberly S. Lakin, Dorota J. Lebiedz‐Odrobina, Yiming Luo, Ashima Makol, Maureen D. Mayes, Zsuzsanna H. McMahan, Jerry Molitor, Duncan F. Moore, Julie Paik, Carrie Richardson, Brian Skaug, Ami A. Shah, Ankoor Shah, Virginia Steen, John M. VanBuren, Elizabeth R. Volkmann, Carleigh Zahn, Nora Sandorfi, for the CONQUER Investigators   +35 more
wiley   +1 more source

The use of nanobodies in a sensitive ELISA test for SARS-CoV-2 Spike 1 protein. [PDF]

R Soc Open Sci, 2021
Girt GC, Lakshminarayanan A, Huo J, Dormon J, Norman C, Afrough B, Harding A, James W, Owens RJ, Naismith JH.   +9 more
europepmc   +1 more source

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, EarlyView.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

A Surface‐engineered Microfluidic Device for Antibody‐Mediated Negative Selection of High‐Quality Sperm for Assisted Reproduction

Advanced Functional Materials, EarlyView.
This study reports a microfluidic device with a functionalized surface utilizing a polyoxazoline coating and covalently immobilized gold nanoparticles and anti‐phosphatidylserine antibody. The device efficiently eliminates pre‐apoptotic and apoptotic spermatozoa and yields sperm with substantially improved quality and low DNA damage, offering a simple ...
Soraya Rasi Ghaemi, David J. Sharkey, Nicole O. McPherson, Markos Negash Alemie, Krasimir Vasilev, Sarah A. Robertson   +5 more
wiley   +1 more source

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19. [PDF]

J Immunol Methods, 2022
Villafañe L, Vaulet LG, Viere FM, Klepp LI, Forrellad MA, Bigi MM, Romano MI, Magistrelli G, Fermepin MR, Bigi F.   +9 more
europepmc   +1 more source

Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma

Advanced Functional Materials, EarlyView.
We have developed DEX/GM, an all‐natural, personalizable hybrid vaccine designed by coating dendritic cell‐derived exosomes (DEX) onto tumor cell membranes (GM) for sustained prophylaxis against glioblastoma (GBM). ABSTRACT Glioblastoma (GBM), one of the most aggressive and lethal brain tumors, remains incurable with a poor clinical prognosis.
Shanshan Li, Dongya Zhang, Shiyu Wang, Changhe Pang, Meng Zheng, Bingyang Shi, Yan Zou   +6 more
wiley   +1 more source

EVALUATION OF COMMERCIAL NEWER RAPID TEST FOR DETECTION OF EARLY ACUTE DENGUE INFECTION

National Journal of Medical Research, 2011
Introduction: We have done a study of evaluation of commercial newer rapid immunochromatographic test for diagnosis of early dengue infection. It detects both NS1 antigen and IgM antibody simultaneously.
Jigna Karia, Hetal Shah, Parul Patel, Jignasa Bhalodia, Hitendra Bhavsar, Gaurishankar Shrimali, Chirag Patel   +6 more
doaj  

Detection of Ampelovirus and Nepovirus by Lab-on-a-Chip: A Promising Alternative to ELISA Test for Large Scale Health Screening of Grapevine. [PDF]

Biosensors (Basel), 2022
Buja I, Sabella E, Monteduro AG, Rizzato S, Bellis L, Elicio V, Formica L, Luvisi A, Maruccio G.   +8 more
europepmc   +1 more source